Asprosin Neutralizing Antibodies as a Treatment for Metabolic Syndrome
I. Mishra, C. Duerrschmid, Z. Ku, W. Xie, E. S. Silva, J. Hoffman, W. Xin, N. Zhang, Z. An, A. Chopra
This paper shows anti-asprosin monoclonal antibodies reduce appetite, body weight, and blood glucose in metabolic syndrome mouse models.
bioRxiv · Sep 15, 2020 · PreprintPhysiology